Ephedrine hydrochloride - Generic Drug Details

What are the generic sources for ephedrine hydrochloride and what is the scope of patent protection?

Ephedrine hydrochloride is the generic ingredient in one branded drug marketed by Dr Reddys Labs Sa and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for ephedrine hydrochloride. One supplier is listed for this compound.

Summary for ephedrine hydrochloride

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	22
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	39
Clinical Trials:	273
Patent Applications:	998
What excipients (inactive ingredients) are in ephedrine hydrochloride?	ephedrine hydrochloride excipients list
DailyMed Link:	ephedrine hydrochloride at DailyMed

Recent Clinical Trials for ephedrine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ankara City Hospital Bilkent	N/A
Kasr El Aini Hospital	N/A
Jason Chui	Phase 4

See all ephedrine hydrochloride clinical trials

Pharmacology for ephedrine hydrochloride

Drug Class	Norepinephrine Releasing Agent alpha-Adrenergic Agonist beta-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Adrenergic beta-Agonists
Physiological Effect	Increased Norepinephrine Activity

Anatomical Therapeutic Chemical (ATC) Classes for ephedrine hydrochloride

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

R01AA	Sympathomimetics, plain
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

R01AB	Sympathomimetics, combinations excl. corticosteroids
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

R03CA	Alpha- and beta-adrenoreceptor agonists
R03C	ADRENERGICS FOR SYSTEMIC USE
R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R	Respiratory system

S01FB	Sympathomimetics excl. antiglaucoma preparations
S01F	MYDRIATICS AND CYCLOPLEGICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for ephedrine hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Sa	REZIPRES	ephedrine hydrochloride	SOLUTION;INTRAVENOUS	213536-004	Dec 7, 2023		RX	Yes	Yes
Dr Reddys Labs Sa	REZIPRES	ephedrine hydrochloride	SOLUTION;INTRAVENOUS	213536-001	Jun 14, 2021		DISCN	Yes	No
Dr Reddys Labs Sa	REZIPRES	ephedrine hydrochloride	SOLUTION;INTRAVENOUS	213536-003	Jun 14, 2021		DISCN	Yes	No
Dr Reddys Labs Sa	REZIPRES	ephedrine hydrochloride	SOLUTION;INTRAVENOUS	213536-002	Jun 14, 2021		DISCN	Yes	No

Ephedrine hydrochloride Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Ephedrine Hydrochloride

Introduction to Ephedrine Hydrochloride

Ephedrine hydrochloride is a medication and stimulant that has been widely used in the pharmaceutical and healthcare industries for various applications, including the treatment of bronchial asthma, weight loss, and performance enhancement. Here, we delve into the market dynamics and financial trajectory of this drug.

Market Size and Growth Projections

The global ephedrine hydrochloride market is experiencing significant growth. As of 2023, the market size was valued at USD 1.2 billion and is projected to reach USD 2.1 billion by 2032, indicating a substantial increase in demand and revenue[5].

Compound Annual Growth Rate (CAGR)

The market is expected to expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031. This growth rate underscores the robust demand for ephedrine hydrochloride across various regions and applications[4].

Geographical Segmentation

The ephedrine hydrochloride market is segmented geographically into several key regions:

• North America: This region dominated the market in 2024, driven by growing consumer demand for weight loss and performance enhancement products. Despite regulatory challenges, the market continues to grow[4].
• Europe: Europe is the fastest-growing region, driven by rising consumer interest in weight control and performance enhancement products. Despite stringent regulatory controls, the market is expanding[4].
• Asia-Pacific: This region holds a significant share of the global market, with a market size estimated to grow at a CAGR of 7.00% from 2024 to 2031[4].
• Latin America: The Latin American market is expected to grow at a CAGR of 4.4% from 2024 to 2031, contributing to the overall global growth[4].
• Middle East and Africa: This region also shows promising growth, with a CAGR of 4.7% from 2024 to 2031[4].

Product Forms and Applications

The market is segmented based on product forms and applications:

• Product Forms: Tablets, capsules, and injections are the primary forms in which ephedrine hydrochloride is available. Tablets are the dominating category, popular among consumers seeking weight control and performance enhancement aids[4].
• Applications: The primary application is in the treatment of bronchial asthma, but it is also used for weight loss and performance enhancement[2].

Market Drivers

Several factors are driving the growth of the ephedrine hydrochloride market:

• Increasing Demand for Weight Loss Products: The global demand for weight loss products is a significant driver, as ephedrine hydrochloride is perceived to be effective in boosting energy levels and aiding in fat burning[4].
• Technological Advancements: Innovations in drug formulations and production processes are enhancing the efficiency and safety of ephedrine hydrochloride products[1].
• Strategic Collaborations: Strategic collaborations and partnerships among key players are improving production and distribution, further driving market growth[1].

Market Restraints

Despite the growth, there are several restraints affecting the market:

• Regulatory Challenges: Stringent regulatory controls in various regions pose a significant challenge to the market. Regulatory frameworks are evolving, and compliance can be complex[4].
• Safety Concerns: Ephedrine hydrochloride has been associated with safety concerns, such as cardiovascular risks, which can impact consumer confidence and regulatory approval[4].

Competitive Landscape

The competitive landscape of the ephedrine hydrochloride market is characterized by:

• Key Players: Companies like Taj Pharmaceuticals and Pfizer are prominent players in the market. These companies are involved in various strategic activities such as partnerships, mergers and acquisitions, and product launches to maintain their market position[2].
• Regional Presence: The market is highly competitive, with companies having a strong regional and industry presence. The competitive landscape segment of market reports provides detailed insights into the ranking of top companies and their recent developments[2].

Market Outlook

The market outlook for ephedrine hydrochloride is positive, with several growth catalysts and opportunities:

• Growth Catalysts: The increasing demand for weight loss and performance enhancement products, coupled with technological advancements, is expected to drive the market forward[4].
• Opportunities: Emerging markets in regions like Asia-Pacific and Latin America offer significant opportunities for growth. The evolving regulatory landscapes in these regions also present new business ventures and investment possibilities[4].

Porter's 5 Forces Framework

The market analysis includes a comprehensive examination using Porter's 5 Forces Framework:

• Threat of New Entrants: The threat of new entrants is moderate due to the presence of established players and regulatory barriers.
• Bargaining Power of Suppliers: The bargaining power of suppliers is relatively low due to the availability of raw materials and the competitive nature of the supplier market.
• Bargaining Power of Buyers: The bargaining power of buyers is moderate, influenced by the availability of alternative products and the level of consumer awareness.
• Threat of Substitute Products: The threat of substitute products is high due to the availability of alternative weight loss and performance enhancement products.
• Competitive Rivalry Among Existing Competitors: The competitive rivalry is high, driven by the presence of multiple players and the need for continuous innovation and market differentiation[2].

Financial Projections

The financial projections for the ephedrine hydrochloride market are robust:

• Revenue Growth: The market is expected to grow from USD 1.2 billion in 2023 to USD 2.1 billion by 2032, indicating a significant increase in revenue[5].
• Market Value: The global ephedrine market size is estimated to expand at a CAGR of 5.00% from 2024 to 2031, reflecting strong financial growth[4].

Key Takeaways

• The ephedrine hydrochloride market is experiencing significant growth driven by increasing demand for weight loss and performance enhancement products.
• Geographical regions such as North America, Europe, and Asia-Pacific are key contributors to the market growth.
• Regulatory challenges and safety concerns are restraints that need to be addressed.
• The competitive landscape is characterized by strategic collaborations and the presence of established players.
• Financial projections indicate robust revenue growth and market expansion.

FAQs

1. What is the projected CAGR for the ephedrine hydrochloride market from 2024 to 2031? The projected CAGR for the ephedrine hydrochloride market from 2024 to 2031 is 5.00%[4].

2. Which region dominates the ephedrine hydrochloride market? North America currently dominates the ephedrine hydrochloride market, driven by growing consumer demand for weight loss and performance enhancement products[4].

3. What are the primary product forms of ephedrine hydrochloride? The primary product forms of ephedrine hydrochloride are tablets, capsules, and injections, with tablets being the dominating category[4].

4. What are the main applications of ephedrine hydrochloride? The main applications of ephedrine hydrochloride include the treatment of bronchial asthma, weight loss, and performance enhancement[2].

5. Who are some of the key players in the ephedrine hydrochloride market? Key players in the ephedrine hydrochloride market include Taj Pharmaceuticals and Pfizer[2].

Sources

1. Market Research Intellect: Ephedrine Hydrochloride Market Dynamics: Innovations Shaping the Future of Pharma and Healthcare.
2. Market Research Intellect: Global Ephedrine Drug Market Size, Trends and Projections.
3. Market Publishers: L-Ephedrine HCl (CAS 50-98-6) Market Research Report 2024.
4. Cognitive Market Research: Global Ephedrine Market Report 2024.
5. Dataintelo: Ephedrine Hydrochloride Market Research Report 2032.